DEC 19, 2015 4:59 AM PST

'Dipstick' Testing For Fatal Sleeping Sickness

WRITTEN BY: Xuan Pham
In West and Central Africa, a bite from the tsetse fly could send a person in to a fatal coma. Doctors have now developed a fast and efficient way to diagnose this condition using a method that’s similar to a dipstick pregnancy test.
 
Blood smear showing presence of the HAT-causing parasite.

African sleeping sickness, also known formally as Human African Trypanosomiasis (HAT), is a disease caused by the parasites Trypanosoma brucei gambiense (T.b. gambiense) or T.b. rhodesiense. Infected tsetse flies transmit the parasite to humans through skin bites. The parasites initially invade the blood and lymphatic system. Then they begin an attack on the host’s central nervous system, causing sleep cycle disruption and neurological damage that can amount to a fatal coma when not treated properly.
 
 
Current methods of diagnosing the sleeping sickness involve highly skilled professionals and multiple complex equipments – resources that are in short supply in the remote Sub-Saharan Africa areas.
 
"I have been involved with MSF mobile HAT screening teams in central African countries for over 10 years. Traditional testing involves a large team in remote areas doing time-consuming microscopic work, and painful lumbar punctures. For this you need electricity and refrigeration.” – Dr. Barrie Rooney, lead author of the study.
 
Working with the international medical charity Medecins Sans Frontieres (MSF) and the Flexible Interchange Programme (FLIP), researchers from the University of Kent developed a next generation diagnostic test that requires a blood sample the size of a pinprick.
 
The basis of this new test is a new genetically engineered parasite that’s similar to T. b. gambiense. This modified organism provided a safe and convenient means for researchers to produce antigens that react against HAT. Similar to antigen-based tests that can tell your blood type, the binding of HAT antigen molecules to a patient’s blood will alert doctors of the disease presence.

"By combining the latest genome databases and old fashioned fermentation techniques we have come up with a fast, simple way of making robust and reliable tests. The new tests are designed to be heat stable and user-friendly like a dipstick pregnancy test.” – Dr. Rooney
 
The new test is classified as a rapid immunochromatography-based serodiagnostic tests (RDTs), and is considered a type of point of care test (POTC). Additionally, it fits all the criteria outlined by the World Health Organization, being “affordable, sensitive, specific, user-friendly, rapid, equipment-free and deliverable to the people at need.” This is quite a remarkable feat considering that the doctors and researchers took only 14 months to develop this rapid diagnostic test.
 
The test is expected to improve the screening and treatment of this disease dramatically. And although it was developed specifically for African sleeping sickness, the basic premise of the diagnostic test could theoretically be adapted for other similar tropical diseases like Chagas and visceral leishmaniasis. 

Additional source: Eurekalert
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
DEC 10, 2020
Clinical & Molecular DX
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
DEC 10, 2020
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
A study by Duke University researchers has revealed that children’s gut microbiomes hold clues as to their possibl ...
JAN 06, 2021
Clinical & Molecular DX
COVID Patients Can't Stop and Smell the Roses
JAN 06, 2021
COVID Patients Can't Stop and Smell the Roses
A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their s ...
JAN 12, 2021
Clinical & Molecular DX
Portable Sequencer Ensures All the Cancer Cells Are Gone
JAN 12, 2021
Portable Sequencer Ensures All the Cancer Cells Are Gone
Surgeons remove a tumor from the abdominal cavity of a patient. But how can they be certain that all the cancer cells we ...
FEB 02, 2021
Clinical & Molecular DX
Keeping an Eye on COVID Clusters With Rapid Sequencing
FEB 02, 2021
Keeping an Eye on COVID Clusters With Rapid Sequencing
Contact tracing is a powerful tool used by public health authorities to help slow the spread of infectious diseases such ...
MAR 04, 2021
Clinical & Molecular DX
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
MAR 04, 2021
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...
Loading Comments...